Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Dec 15;2015(12):CD001917.
doi: 10.1002/14651858.CD001917.pub4.

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

Albert Balaguer  1 , Javier González de Dios
Affiliations
Meta-Analysis

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

Albert Balaguer et al. Cochrane Database Syst Rev. .

Abstract

Background: Recurrent endobronchial infection in cystic fibrosis requires treatment with intravenous antibiotics for several weeks usually in hospital, affecting health costs and quality of life for patients and their families. This is an update of a previously published review.

Objectives: To determine whether home intravenous antibiotic therapy in cystic fibrosis is as effective as inpatient intravenous antibiotic therapy and if it is preferred by individuals or families or both.

Search methods: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register comprising references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings.Most recent search of the Group's Trials Register: 23 November 2015.

Selection criteria: Randomized and quasi-randomized controlled studies of intravenous antibiotic treatment for adults and children with cystic fibrosis at home compared to in hospital.

Data collection and analysis: The authors independently selected studies for inclusion in the review, assessed methodological quality of each study and extracted data using a standardised form.

Main results: Eighteen studies were identified by the searches. Only one study could be included which reported results from 17 participants aged 10 to 41 years with an infective exacerbation of Pseudomonas aeruginosa. All their 31 admissions (18 hospital and 13 at home after two to four days of hospital treatment) were analysed as independent events. Outcomes were measured at 0, 10 and 21 days after initiation of treatment. Home participants underwent fewer investigations than hospital participants (P < 0.002) and general activity was higher in the home group. No significant differences were found for clinical outcomes, adverse events, complications or change of intravenous lines,or time to next admission. Home participants received less low-dose home maintenance antibiotic.Quality of life measures showed no significant differences for dyspnoea and emotional state, but fatigue and mastery were worse for home participants, possibly due to a higher general activity and need of support. Personal, family, sleeping and eating disruptions were less important for home than hospital admissions.Home therapy was cheaper for families and the hospital. Indirect costs were not determined.

Authors' conclusions: Current evidence is restricted to a single randomized clinical trial. It suggests that, in the short term, home therapy does not harm individuals, entails fewer investigations, reduces social disruptions and can be cost-effective. There were both advantages and disadvantages in terms of quality of life. The decision to attempt home treatment should be based on the individual situation and appropriate local resources. More research is urgently required.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

References

References to studies included in this review

Wolter 1997 {published data only}
    1. Wolter J, Bowler S, Nolan P, McCormack J. Intravenous home therapy: a randomised trial in adult cystic fibrosis patients [abstract]. Australian & New Zealand Journal of Medicine 1995;25:567.
    1. Wolter JM, Bowler SD, Nolan PJ, McCormack JG. Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. European Respiratory Journal 1997;10(4):896-900. - PubMed

References to studies excluded from this review

Amelina 2000 {published data only}
    1. Amelina E, Senkevich N, Cherniak A, Cherniaev A, Chuchalin A. Home intravenous therapy in adult cystic fibrosis patients. The impact on lung fuction and quality of life [abstract]. European Respiratory Journal 2000;Suppl 31:123s.
Bosworth 1997 {published data only}
    1. Bosworth DG, Nielson DW. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatric Pulmonology 1997;24(1):42-7. - PubMed
Davis 1990 {published data only}
    1. Davis S, Mather F, Tankersly P, Waring W, The Home IV Antibiotic Study Group. A randomized trial of home intravenous antibiotic therapy (HIVAT) in Cystic Fibrosis (CF): Short-Term Safety and efficacy [abstract]. Pediatric Pulmonology 1990;Suppl 5:207.
    1. Davis S, Mather F, Waring W, The Home IV Antibiotic Study Group. A randomized trial of home intravenous antibiotic therapy (HIVAT) in Cystic Fibrosis (CF): Short-Term psychological effects [abstract]. Pediatric Pulmonology 1990;Suppl 5:338.
Donati 1987 {published data only}
    1. Donati MA, Guenette G, Auerbach H. Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease. Journal of Pediatrics 1987;111(1):28-33. - PubMed
Esmond 2006 {published data only}
    1. Esmond G, Butler M, McCormack AM. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. Journal of Clinical Nursing 2006;15(1):52-60. [MEDLINE: ] - PubMed
Girón 2004 {published data only}
    1. Girón RM, Martínez A, Máiz L, Salcedo A, Beltrán B, Martínez MT, et al. Home intravenous antibiotic treatments in cystic fibrosis units of Madrid. Medicina clínica 2004;122(17):648-52. [MEDLINE: ] - PubMed
Girón 2006 {published data only}
    1. Girón RM, Cisneros C, Nakeeb ZA, Hoyos N, Martínez C, Ancochea J. Efficiency of the home intravenous antibiotics treatment in cystic fibrosis. Medicina clínica 2006;127(15):567-71. [MEDLINE: ] - PubMed
Graf 1997 {published data only}
    1. Graf von der Schulenburg JM, Greiner W, Klettke U, Wahn U. Economic aspects in treatment of cystic fibrosis with chronic pulmonary pseudomonas infection. Ambulatory intarvenous therapy in comparison with inpatient treatment [Ökonomische Aspekte der Behandlung zysticher Fibrose mit chronischer pulmonaler Pseudomonasinfektion. Ambulante intravenöse Therapie im Vergleich zur stationären Behandlung]. Medizinische Klinik 1997;92(10):626-9. - PubMed
    1. Klettke U, Maagdorf K, Staab D, Paul K, Wahn U. Ambulatory vs. inpatient intravenous antibiotic therapy in mucoviscidosis patients - a controlled study. Pneumologie 1999;53(1):31-6. - PubMed
    1. Magdorf K, Klettke U, Staab D, Paul K, Wahn U. Home intravenous antibiotic therapy vs. hospital therapy - an alternative for patients with cystic fibrosis? Monatsschrift Fur Kinderheilkunde 1996;144:1047.
Horvais 2006 {published data only}
    1. Horvais V, Touzet S, François S, Bourdy S, Bellon G, Colin C, et al. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France. International journal of technology assessment in health care 2006;22(4):525-31. [MEDLINE: ] - PubMed
Nazer 2006 {published data only}
    1. Nazer D, Abdulhamid I, Thomas R, Pendleton S. Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis. Pediatric Pulmonology 2006;41(8):744-9. [MEDLINE: ] - PubMed
Ramström 2000 {published data only}
    1. Ramström H, Erwander I, Mared L, Kornfält R, Seiving B. Pharmaceutical intervention in the care of cystic fibrosis patients. Journal of Clinical Pharmacy and Therapeutics 2000;25(6):427-34. - PubMed
Riethmueller 2002 {published data only}
    1. Riethmueller J, Busch A, Damm V, Ziebach R, Stern M. Home and hospital antibiotic treatment prove similarly effective in cystic fibrosis. Infection 2002;30(6):387-91. [MEDLINE: ] - PubMed
Riethmueller 2009 {published data only}
    1. Riethmueller J, Ballmann M, Schroeter TW, Franke P, Butler R, Claass A, et al. Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients. Infection 2009;37(5):424-31. - PubMed
    1. Riethmueller J, Busch A, Franke P, Ziebach R, Butler R, Stern M. Pharmacodynamic variation of intravenous antibiotic treatment with ceftazidime and tobramycin in CF-patients is equally effective [abstract]. In: Proceedings of the 13th International Cystic Fibrosis Congress; 2000 June 4-8; Stockholm, Sweden. 2000:166.
    1. Riethmueller J, Franke P, Schroeter TW, Claass A, Busch A, Ziebach R, et al. Optimised intravenous antibiotic treatment with ceftazidime (thrice daily vs continuous) and tobramycin (thrice vs once daily) in CF patients [abstract]. In: Proceedings of the 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria. 2001:P192.
    1. Riethmueller J, Junge S, Schroeter TW, Kuemmerer K, Franke P, Ballmann M, et al. Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis. Infection 2009;37(5):418-23. - PubMed
    1. Schroeter T, Eggert P, Riethmueller J, Stern M, Claass A. Acute-phase nephrotoxicity of tobramycin in CF patients: A prospective randomized trial of once-versus thrice-daily dosing [abstract]. Pediatric Pulmonology 2002;34(Suppl 24):289.
Romano 1991 {published data only}
    1. Romano L, Girosi D, Spallone E, Parisi L, Minucci L, Romano C. Ofloxacin in the treatment of cystic fibrosis [Uso dell'ofloxacin nei pazienti con fibrosis cistica]. Minerva Pediatrica 1992;44(3):79-86. - PubMed
    1. Romano L, Minicucci L, Spallone E, Girosi D, Campelli A, Fabbri A, et al. Role of home therapy with ofloxacin in patients with cystic fibrosis (CF) [Ruolo della terapia domiciliare con ofloxacin in pazienti con fibrosi cistica (FC)]. Giornale Italiano de Chemioterapia 1991;38(13):181-3. - PubMed
Thornton 2005 {published data only}
    1. Elliott RA, Thornton J, Webb AK, Dodd M, Tully MP. Comparing costs of home- versus hospital-based treatment of infections in adults in a specialist cystic fibrosis center. International Journal of Technology Assessment in Health Care 2005;21(4):506-10. - PubMed
    1. Thornton J, Elliott R, Tully MP, Dodd M, Webb AK. Free Full TextLong term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis. Thorax 2004;59(3):242-6. [MEDLINE: ] - PMC - PubMed
    1. Thornton J, Elliott RA, Tully MP, Dodd M, Webb AK. Clinical and economic choices in the treatment of respiratory infections in cystic fibrosis: comparing hospital and home care. Journal of Cystic Fibrosis 2005;4(4):239-47. [MEDLINE: ] - PubMed
Wolter 2004 {published data only}
    1. Wolter JM, Cagney RA, McCormack JG. A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases. Journal of Infection 2004;48(3):263-8. [MEDLINE: ] - PubMed

References to studies awaiting assessment

Hjelte 1988 {published data only}
    1. Hjelte L, Widen B, Malmborg AS, Freyschuss U, Strandvik B. [Intravenous administration of antibiotics at home in patients with cystic fibrosis improves quality of life] [Intravenos antibiotikabehandling i hemmet vid cystisk fibros ger okad livskvalitet]. Lakartidningen 1988;(18):1614-7. - PubMed

Additional references

Bell 2000
    1. Bell SC, Bowerman AM, Nixon LE, Macdonald IA, Elborn JS, Shale DJ. Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. European Journal of Clinical Investigation 2000;30(6):553-9. - PubMed
Collaco 2010
    1. Collaco JM, Green DM, Cutting GR, Naughton KM, Mogayzel PJ. Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes. American Journal of Respiratory and Critical Care Medicine 2010;182(9):1137-43. - PMC - PubMed
Dasenbrook 2010
    1. Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010;303(23):2386–92. - PubMed
David 1986
    1. David TJ. Intravenous antibiotics at home in children with cystic fibrosis. Journal of the Royal Society of Medicine 1986;82(3):130-1. - PMC - PubMed
DeMets 1987
    1. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50. - PubMed
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88. - PubMed
Egger 1997
    1. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34. - PMC - PubMed
Flume 2009
    1. Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC, Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. American Journal of Respiratory and Critical Care Medicine 2009;180(9):802-8. - PubMed
Gilbert 1988
    1. Gilbert J, Robinson T, Littlewood JM. Home intravenous antibiotic treatment in cystic fibrosis. Archives of Disease in Childhood 1988;63(5):512-7. - PMC - PubMed
Gilchrist 2009
    1. Gilchrist FJ, Lenney W. A review of the home intravenous antibiotic service available to children with cystic fibrosis. Archives of Disease in Childhood 2009;94(8):647. - PubMed
Harrison 2007
    1. Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology 2007;153(Pt 4):917-23. - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [MEDLINE: ] - PMC - PubMed
Jones 2003
    1. Jones AM, Webb AK. Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and pandoraea spp. Journal of the Royal Society of Medicine 2003;96(Suppl 43):66-72. - PMC - PubMed
Jüni 2001
    1. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6. [MEDLINE: ] - PMC - PubMed
Kosorok 1996
    1. Kosorok MR, Wei WH, Farrell TM. The incidence of cystic fibrosis. Statistics in Medicine 1996;15(5):449-62. - PubMed
Macaskill 2001
    1. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4):641-54. - PubMed
Moran 2010
    1. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010;33(12):2697-708. - PMC - PubMed
Pond 1994
    1. Pond MN, Newport M, Joanes D, Conway SP. Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis. European Respiratory Journal 1994;7(9):1640-4. - PubMed
Proesmans 2009
    1. Proesmans M, Heyns L, Moons P, Havermans T, De Boeck K. Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: outcome of home therapy is not inferior. Respiratory Medicine 2009;103(2):244-50. - PubMed
Rucker 1974
    1. Rucker RW, Harrison GM. Outpatient intravenous medication in the management of cystic fibrosis. Pediatrics 1974;54(3):358-60. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment in controlled trials. JAMA 1995;273(5):408-12. - PubMed
Sequeiros 2009
    1. Sequeiros IM, Jarad NA. Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis - Is it good for the patient? Annals of Thoracic Medicine 2009;4(3):111-4. - PMC - PubMed
Shepperd 2008
    1. Shepperd S, Doll H, Angus RM, Clarke MJ, Iliffe S, Kalra L, et al. Hospital at home admission avoidance. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No: CD007491. [DOI: 10.1002/14651858.CD007491] - DOI - PMC - PubMed
Strandvik 1992
    1. Strandvik B, Hjelte L, Malmborg AS, Widen B. Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatrica 1992;81(4):340-4. - PubMed
van der Laag 1995
    1. Laag J, Van de Weg L. Cystic fibrosis and outpatient treatment with parenteral antibiotics in children. International Journal of Antimicrobial Agents 1995;5:63-5. - PubMed
Waters 2011
    1. Waters V, Yau Y, Prasad S, Lu A, Atenafu E, Crandall I, et al. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. American Journal of Respiratory and Critical Care Medicine 2011;183(5):635-40. - PubMed

References to other published versions of this review

Asensio 2000
    1. O Asensio, M Bosque, T Marco, J de Gracia, C Serra. Home versus hospital intravenous antibiotic therapy for cystic fibrosis. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No: CD001917. [DOI: 10.1002/14651858.CD001917] - DOI - PubMed
Balaguer 2008
    1. Balaguer A, González de Dios J. Home versus hospital intravenous antibiotic therapy for cystic fibrosis. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No: CD001917. [DOI: 10.1002/14651858.CD001917] - DOI - PubMed
Balaguer 2012
    1. Balaguer A, González de Dios J Cochrane Database of Systematic Reviews 2012. Home versus hospital intravenous antibiotic therapy for cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No: CD001917. [DOI: 10.1002/14651858.CD001917.pub3] - DOI - PubMed

Substances